Fingerprint
Dive into the research topics of 'Estimation of Percentage of Patients With Fibroblast Growth Factor Receptor Alterations Eligible for Off-label Use of Erdafitinib'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Estimation of Percentage of Patients With Fibroblast Growth Factor Receptor Alterations Eligible for Off-label Use of Erdafitinib
Lelia Maria de Almeida Carvalho, Sandra de Oliveira Sapori Avelar, Alyson Haslam, Jennifer Gill, Vinay Prasad
Research output: Contribution to journal › Article › peer-review
17
Scopus
citations